Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection
Microvascular inflammation (MVI) is a central feature of allograft rejection, traditionally associated with antibody-mediated rejection (AMR), but its mechanisms and clinical impact extend beyond this framework. This review highlights recent updates in the Banff classification, insights into the mec...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
May 2026
|
| In: |
Current opinion in nephrology and hypertension
Year: 2026, Volume: 35, Issue: 3, Pages: 316-322 |
| ISSN: | 1062-4813 |
| DOI: | 10.1097/MNH.0000000000001165 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/MNH.0000000000001165 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-nephrolhypertens/abstract/2026/05000/microvascular_inflammation_in_the_kidney.7.aspx 
|
| Author Notes: | Aurélie Sannier, Louise Benning, Alexandre Loupy |
| Summary: | Microvascular inflammation (MVI) is a central feature of allograft rejection, traditionally associated with antibody-mediated rejection (AMR), but its mechanisms and clinical impact extend beyond this framework. This review highlights recent updates in the Banff classification, insights into the mechanisms underlying MVI, and how these developments may refine diagnostic approaches and guide the development of therapeutic strategies |
|---|---|
| Item Description: | Gesehen am 24.06.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1062-4813 |
| DOI: | 10.1097/MNH.0000000000001165 |